Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...

Pharmacists and doctors can make compounded medications by combining, mixing, or altering various ingredients to meet a specific need. But because these medications don’t have Food and Drug ...

Through Hubron’s established distributor network, HydroGraph expects expanded access to key markets including automotive, construction, electronics, film, pipe, wire and cable, and technical ...